CEA, MCA, CA 15.3 and CA 549 and Their Combinations in Expressing and Monitoring Metastatic Breast Cancer: a Prospective Comparative Study

By Martoni A.   Zamagni C.   Bellanova B.   Zanichelli L.   Vecchi F.   Cacciari N.   Strocchi E.   Pannuti F.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1615-1621

Elsevier

Access to resources Recommend Favorite

Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers

By Lee Jun   Park Seho   Park Ji   Cho Jung   Kim Seung   Park Byeong-Woo  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 477-484

Springer Publishing Company

Access to resources Recommend Favorite

Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis

By Dede Didem  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1429-1429

Humana Press, Inc

Access to resources Recommend Favorite

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

By D’Alessandro R.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 1, 2001-07 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite

Serum Tumor Marker CA 15.3 and Stage are the Two Most Powerful Predictors of Survival in Primary Breast Cancer

By Kumpulainen E.J.   Keskikuru R.J.   Johansson R.T.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 95-102

Springer Publishing Company

Access to resources Recommend Favorite